Ventas, Inc.

VTR

US92276F1003

Specialized REITs

Market Closed - Nyse Other stock markets 04:00:01 2024-04-25 pm EDT			5-day change	1st Jan Change
43.36 ^USD	-0.57%		+1.69%	-13.00%

Apr. 24	Ventas, Inc. Closes Extended and Improved $2.75 Billion Unsecured Credit Facility	CI
Mar. 18	Evercore ISI Upgrades Ventas to Outperform From In Line, Price Target is $50	MT

Glass Lewis & Co LLC Supports Ventas Inc Board Nominees

April 20, 2022 at 10:13 am EDT

On April 20, 2022, Ventas Inc announced that an independent proxy advisory firm, Glass Lewis & Co LLC has recommended the shareholders to vote for all Company nominees to the board, at the annual meeting of shareholders scheduled to be held on April 27, 2022.

Latest news about Ventas, Inc.

Ventas, Inc. Closes Extended and Improved $2.75 Billion Unsecured Credit Facility	Apr. 24	CI
Evercore ISI Upgrades Ventas to Outperform From In Line, Price Target is $50	Mar. 18	MT
Ventas, Inc. Declares First Quarter 2024 Dividend, Payable on April 18, 2024	Mar. 12	CI
Ventas ramps up acquisitions in property for senior citizens : Ventas CEO	Mar. 08	MT
Transcript : Ventas, Inc. Presents at Citi's 2024 Global Property CEO Conference, Mar-05-2024 04:20 PM	Mar. 05
Ventas Appoints Theodore Bigman and Joe V. Rodriguez to Board of Directors	Mar. 04	CI
Ventas, Inc. Announces Board Changes	Mar. 04	CI
Ventas Prices Senior Notes Offering	Mar. 01	MT
How long will this bullish phase last?	Feb. 26
Wells Fargo Downgrades Ventas to Equalweight From Overweight, Adjusts Price Target to $46 From $52	Feb. 26	MT
ANALYST RECOMMENDATIONS : AbbVie, Doordash, Eli Lilly, Moderna, Hiscox...	Feb. 26
Transcript : Ventas, Inc., Q4 2023 Earnings Call, Feb 15, 2024	Feb. 15
Healthcare REIT Ventas reports rise in Q4 FFO	Feb. 14	RE
Ventas Q4 Normalized FFO, Revenue Rise; 2024 FFO Guidance Set	Feb. 14	MT
Earnings Flash (VTR) VENTAS Reports Q4 Revenue $1.16B	Feb. 14	MT
Ventas, Inc. Provides Earnings Guidance for the Year 2024	Feb. 14	CI
Ventas, Inc. Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2023	Feb. 14	CI
'No Landing' scenarios swirl as markets recoil	Feb. 14	RE
Ventas, Inc. acquired Residence at Orchard Grove from Blue Moon Capital Partners LLC.	Jan. 21	CI
Sector Update: Health Care Stocks Weaker Late Afternoon	Jan. 16	MT
Sector Update: Health Care Stocks Softer Tuesday Afternoon	Jan. 16	MT
Ventas' Strong Growth to Flow Into 2024, 2025 Earnings, BofA Securities Says; Stock Upgraded to Buy	Jan. 16	MT
BofA Upgrades Ventas to Buy From Neutral on External Growth Opportunities, Adjusts Price Target to $53 From $48	Jan. 16	MT
Ventas Confirms Receipt of Director Nominations from Land & Buildings	Jan. 11	CI
Ventas Says it Received Three Director Nominations from Activist Investor; Board to Issue Recommendation	Jan. 11	MT

Chart Ventas, Inc.

Duration

Period

More charts

Company Profile

Ventas, Inc. specializes in owning and managing healthcare and medical-residential facilities. At the end of 2022, the group's portfolio included 1,237 assets consisting primarily of senior housing (802), medical office buildings (313), rehabilitation and long-term acute care facilities (36), laboratories and research facilities (32), skilled nursing facilities (16), medical and surgical facilities (13). Net sales are distributed geographically as follows: the United States (88.5%), Canada (10.9%) and the United Kingdom (0.6%).

Sector

Specialized REITs

Calendar

2024-04-30 - Q1 2024 Earnings Release

Related indices

S&P 500

More about the company

Income Statement Evolution

More financial data

Analysis / Opinion

Ventas ramps up acquisitions in property for senior citizens : Ventas CEO

March 08, 2024 at 03:32 pm EST

More Strategies

Ratings for Ventas, Inc.

Trading Rating

Investor Rating

ESG Refinitiv

A-

More Ratings

Analysts' Consensus

Sell

Buy

Mean consensus

BUY

Number of Analysts

Last Close Price

43.61 USD

Average target price

52.47 USD

Spread / Average Target

+20.32%

Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Healthcare REITs

	1st Jan change	Capi.
VENTAS, INC.	-13.00%	17.56B
WELLTOWER INC.	+4.25%	55.38B
HEALTHPEAK PROPERTIES, INC.	-7.37%	13.22B
OMEGA HEALTHCARE INVESTORS, INC.	+0.78%	7.58B
HEALTHCARE REALTY TRUST INCORPORATED	-16.54%	5.49B
CARETRUST REIT, INC.	+7.02%	3.21B
SABRA HEALTH CARE REIT, INC.	-4.34%	3.17B
AEDIFICA SA	-6.99%	3.04B
MEDICAL PROPERTIES TRUST, INC.	-7.13%	2.77B
NATIONAL HEALTH INVESTORS, INC.	+12.10%	2.73B

Healthcare REITs

Ventas, Inc.

Equities

VTR

US92276F1003

Specialized REITs

Glass Lewis & Co LLC Supports Ventas Inc Board Nominees

EPS Revisions